This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their observational study, Dr Zandi and colleagues¹ found an apparent reduction of about 40% in risk of AD among women who reported using HRT. In their accompanying Editorial, Drs Resnick and Henderson cite the fact that the reduction was greater for longer duration use as possible evidence that the reduction is not due to "healthy user" bias.² Just as in the case of AD, observational studies have found large reductions in risk of coronary heart disease among users of ERT, and the reductions were greater for longer durations of use.³ However, the final standard for assessing the potential protective effect of ERT is a randomized controlled trial; randomization would eliminate healthy user bias. Results of 2 such trials, the Heart and Estrogen/Progestin Replacement Study⁴ and the Women's Health Initiative,⁵ have recently indicated that estrogen/progestin supplements do not prevent coronary heart disease and may even increase the . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Estrogen Replacement and Risk of Alzheimer Disease
Mark A. Smith, George Perry, Craig S. Atwood, and Richard L. Bowen
JAMA. 2003;289(9):1100.
EXTRACT | FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
Amnon Lahad and Lev Ishay
JAMA. 2003;289(9):1100-1101.
EXTRACT | FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease
J. Galen Buckwalter, Diana B. Petitti, and Valerie C. Crooks
JAMA. 2003;289(9):1101.
EXTRACT | FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease—Reply
Peter P. Zandi and John C. S. Breitner
JAMA. 2003;289(9):1101-1102.
EXTRACT | FULL TEXT  

Estrogen Replacement and Risk of Alzheimer Disease—Reply
Susan M. Resnick and Victor W. Henderson
JAMA. 2003;289(9):1102.
EXTRACT | FULL TEXT  

Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women: The Cache County Study
Peter P. Zandi, Michelle C. Carlson, Brenda L. Plassman, Kathleen A. Welsh-Bohmer, Lawrence S. Mayer, David C. Steffens, John C. S. Breitner, and for the Cache County Memory Study Investigators
JAMA. 2002;288(17):2123-2129.
ABSTRACT | FULL TEXT  

Hormone Therapy and Risk of Alzheimer Disease: A Critical Time
Susan M. Resnick and Victor W. Henderson
JAMA. 2002;288(17):2170-2172.
EXTRACT | FULL TEXT  

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators
JAMA. 2002;288(3):321-333.
ABSTRACT | FULL TEXT  

Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)
Deborah Grady, David Herrington, Vera Bittner, Roger Blumenthal, Michael Davidson, Mark Hlatky, Judith Hsia, Stephen Hulley, Alan Herd, Steven Khan, L. Kristin Newby, David Waters, Eric Vittinghoff, Nanette Wenger, and for the HERS Research Group
JAMA. 2002;288(1):49-57.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Three-Part Intervention To Change the Use of Hormone Replacement Therapy in Response to New Evidence
Roumie et al.
ANN INTERN MED 2004;141:118-125.
ABSTRACT | FULL TEXT